- Home
- BCRX vs SONO Comparison
BCRX vs SONO Comparison
Compare BCRX & SONO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BCRX | SONO |
|---|---|---|
| Founded | 1986 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Consumer Electronics/Video Chains |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.8B |
| IPO Year | 1995 | 2018 |
Fundamental Metrics
Financial Performance| Metric | BCRX | SONO |
|---|---|---|
| Price | $9.55 | $13.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 3 |
| Target Price | ★ $20.82 | $19.67 |
| AVG Volume (30 Days) | ★ 5.5M | 1.9M |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 381.40 | N/A |
| EPS | N/A | ★ 0.52 |
| Revenue | $25,186,000.00 | ★ $1,443,276,000.00 |
| Revenue This Year | N/A | $5.04 |
| Revenue Next Year | $12.55 | $6.53 |
| P/E Ratio | ★ N/A | $26.10 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.00 | $10.12 |
| 52 Week High | $10.94 | $19.82 |
Technical Indicators
Market Signals| Indicator | BCRX | SONO |
|---|---|---|
| Relative Strength Index (RSI) | 58.79 | 35.33 |
| Support Level | $8.04 | $12.67 |
| Resistance Level | $10.04 | $15.69 |
| Average True Range (ATR) | 0.49 | 0.71 |
| MACD | 0.13 | -0.20 |
| Stochastic Oscillator | 50.88 | 11.90 |
Price Performance
Historical ComparisonAbout BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About SONO Sonos Inc.
Sonos Inc is an audio company dedicated to elevating life through sound, offering a connected platform that brings together music, movies, stories, and conversations. Its portfolio includes home theater speakers, components, plug-in and portable speakers and headphones, known for exceptional sound, thoughtful design, ease of use and seamless access to audio content. Its partner products and other revenue categories include accessories for home integration, such as custom-designed stands, mounts, and shelving units, along with partnerships for architectural speakers and automotive sound systems, as well as licensing, advertising revenue, and subscription-based services. The company operates in the United States and other countries, with the majority of revenue coming from the United States.